In the Canadian medical devices industry, there were five M&A deals announced in Q3 2024, worth a total value of $1bn, according to GlobalData’s Deals Database. The $984.2m acquisition of LifeLabs by Quest Diagnostics was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q3 2024 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
In value terms, M&A activity in Canada increased by 11264% in Q3 2024 compared with the previous quarter’s total of $8.8m. Related deal volume decreased by 17% in Q3 2024 versus the previous quarter and was 150% higher than in Q3 2023.
The top-ranked financial advisors supporting these M&A deals in Canada in 9M 2024 were Canadian Imperial Bank of Commerce; Clairfield International; Evercore with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in Canada in 9M 2024 were John Wood Group; McCarthy Tetrault; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q3 2024 – Strategic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.